Cyclacel Pharmaceuticals, Inc.

CYCCNASDAQHealthcare

$6.37

$-0.41(-5.98%)

Market Cap$10608329

P/E Ratio—

52W High$597.59973

52W Low$3.0801

Avg Volume1.8M

Open$6.76

Beta0.16

Forecast Market Cap PE Ratio

Cyclacel Pharmaceuticals, Inc.（CYCC）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

cycc · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2025年11月25日

分析师评级与共识

基于过去 3 个月内 7 位华尔街分析师

Buy

7 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 7 · 买入占比: 71.4%

12 个月目标价

High

$1.00

Consensus

$1.00

-80.6% upside

Low

$1.00

Median: $1 · Last Close: $5.16

Cyclacel Pharmaceuticals, Inc.（CYCC）的分析师共识为 Buy，基于过去 3 个月内 7 位华尔街分析师的评级。CYCC 的 12 个月平均目标价为 $1.00，相对当前价 $5.16 代表 -80.6% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-10	$5.16	↓ 0.06%	$5.11	$5.21

1-day model range: $5.11–$5.21. Peak: $5.21 (-0.06%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

36%35%29%

5Buy

5Neutral

4Sell

RSI (14)59.2Neutral

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · CYCC · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$4.90BUY

MA 10$4.90BUY

MA 20$4.90BUY

MA 50$6.81SELL

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $CYCC · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$4.99BUY

EMA 10$4.95BUY

EMA 20$5.29SELL

EMA 50$7.34SELL

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $CYCC · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2024-05-03	Roth MKM	Maintains	Buy→Buy
2023-12-19	Brookline Capital	Downgrade ↓	Buy→Hold
2023-12-19	Roth MKM	Maintains	Buy→Buy
2023-05-24	Oppenheimer	Maintains	Outperform→Outperform
2023-03-06	Oppenheimer	Maintains	Outperform→Outperform
2021-04-30	Oppenheimer	Maintains	Outperform→Outperform
2020-11-25	JMP Securities	Downgrade ↓	Market Outperform→Perform
2020-11-25	H.C. Wainwright	Maintains	Buy→Buy
2020-11-25	Roth Capital	Maintains	Buy→Buy
2018-09-05	Roth Capital	Maintains	Buy→Buy

Roth MKM2024-05-03

Maintains

Buy→Buy

Brookline Capital2023-12-19

Downgrade ↓

Buy→Hold

Roth MKM2023-12-19

Maintains

Buy→Buy

Oppenheimer2023-05-24

Maintains

Outperform→Outperform

Oppenheimer2023-03-06

Maintains

Outperform→Outperform

Oppenheimer2021-04-30

Maintains

Outperform→Outperform

JMP Securities2020-11-25

Downgrade ↓

Market Outperform→Perform

H.C. Wainwright2020-11-25

Maintains

Buy→Buy

Roth Capital2020-11-25

Maintains

Buy→Buy

Roth Capital2018-09-05

Maintains

Buy→Buy

Wall Street analysts have recently issued updated ratings on Cyclacel Pharmaceuticals, Inc. (CYCC) stock. Of the recent 15 rating actions, 0 were upgrades and 4 were downgrades. 7 analysts currently cover CYCC.

分析师推荐趋势

Buy ratings2 → 1↓ 1

Hold ratings1 → 0↓ 1

Sell ratings0 → 0

CYCC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$0M

↓ 47.0% YoY

Revenue Next Year

$0M

↑ 88.7% YoY

EPS This Year

$-468.00

EPS Next Year

$-283.20

↓ 39.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CYCC EPS of $-468.00 for the current fiscal year, based on estimates from 1 analysts. The CYCC revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CYCC 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CYCC 的共识目标价为 $1.00（-80.6% 上行空间），分析师共识为 Buy。

CYCC 的短期预测（明日）为 $5.16（-0.06%）。

Cyclacel Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 CYCC。CYCC 在 2027 年的整体展望偏积极，在覆盖分析师中约 71% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

CYCC 预测 · 8 个问题

根据 7 位华尔街分析师，CYCC 的 12 个月平均目标价为 $1.00，最高 $1.00、最低 $1.00。若有图表，中位目标价可在上方查看。相对当前价 $5.16，隐含约 -80.6% 的上行空间。

CYCC 目标价CYCC 分析师目标价CYCC 12个月目标价目标价 CYCC

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.